Hit enter to search or ESC to close
3DBio
  • About Us
  • Technology
  • Pipeline
  • News & Media
  • Careers
  • Contact Us
Category

Press Release

Press Release

3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

Press Release

3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

Press Release

3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors

3D Bio Holdings Inc.

2 St. Nicholas Ave
Suite 53
Brooklyn, NY 11237
United States

3D Bio Holdings Inc.

430 East 29th Street
14th Floor
New York, NY 10282
United States

© 2021 3DBio. 3D Bio Therapeutics - All Rights Reserved

  • About Us
  • Technology
  • Pipeline
  • News & Media
  • Careers
  • Contact Us